CEM Completes Acquisition Transition of Intavis Bioanalytical Instruments Assets

Download File


Matthews, N.C. May 5th, 2020 – CEM Corporation is pleased to announce that it now has assumed global sales, service, and support responsibility for the former instrumentation line of Intavis Bioanalytical Instruments AG. This marks the next step in the transition period of the previously announced purchase of the assets of Intavis Bioanalytical Instruments AG. CEM is now directly offering the following updated products:

Peptide Synthesis

MultiPep 1 (formerly ResPep SLi)
MultiPep 2 (formerly MultiPep RSi)
CleavagePro
Slide Spotting Robot

Protein Digestion

DigestPro (formerly DigestPro MSi)

In situ Hybridization & Immunohistochemistry

InsituPro (formerly InsituPro VSi)

Existing customers of Intavis Bioanalytical Instruments can also now receive support from CEM and its worldwide distributor network.

About CEM

CEM Corporation is a global, privately held technology company, based in Matthews, North Carolina. CEM designs, manufactures and distributes products for use in life sciences, analytical laboratories and processing plants worldwide. CEM operates foreign subsidiaries in the United Kingdom, Ireland, Germany, Italy, France, and Japan and has a global network of over fifty third-party distributors.

About Intavis AG:

Intavis AG is a member of HB Technologies AG group located in Tübingen, Germany. The Bioanalytical Instruments line is under development to provide new products in the near future. Please check upcoming Press Releases by HB Technologies AG group for further information: https://www.h-net.com


For more information, contact CEM Corporation

Michael Karney
Life Science Product Manager
michael.karney@cem.com